CANADIAN MARKETING CODES - HOW WELL ARE THEY CONTROLLING PHARMACEUTICAL PROMOTION

Authors
Citation
J. Lexchin, CANADIAN MARKETING CODES - HOW WELL ARE THEY CONTROLLING PHARMACEUTICAL PROMOTION, International journal of health services, 24(1), 1994, pp. 91-104
Citations number
55
Categorie Soggetti
Heath Policy & Services
ISSN journal
00207314
Volume
24
Issue
1
Year of publication
1994
Pages
91 - 104
Database
ISI
SICI code
0020-7314(1994)24:1<91:CMC-HW>2.0.ZU;2-#
Abstract
Pharmaceutical promotion in Canada is controlled by two codes: a volun tary one developed by the Pharmaceutical Advertising Advisory Board de aling mostly with printed promotional material, and one from the Pharm aceutical Manufacturers Association of Canada covering other forms of promotion. This article looks at enforcement of the provisions of thes e codes and at areas in which they are deficient. One of the major wea knesses in both codes is their lack of effective sanctions for compani es that violate their provisions. Strong codes are necessary because m any physicians rely heavily on promotional material for their source o f prescribing information. However, voluntary codes or codes developed by the industry are inherently weak and lack effective enforcement me chanisms. Although the U.S. Food and Drug Administration is currently very active in curtailing promotional excesses, government control is not the solution since regulatory action will depend on the ideologica l position of the head of the regulatory body and/or the party in powe r. An independent body backed by legislative authority is preferable.